NSUN2 and gastric cancer: Supporting this, the results from GC cell line-based xenograft (CDX) models showed that NONO or NSUN2 knockdown significantly inhibited the subcutaneous growth of CDX tumors generated from the MKN-45 cell line (Fig. S7D).